标题
Review: Practical considerations in ovarian cancer chemotherapy
作者
关键词
-
出版物
Therapeutic Advances in Medical Oncology
Volume 2, Issue 3, Pages 175-187
出版商
SAGE Publications
发表日期
2010-02-17
DOI
10.1177/1758834010361333
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A phase II evaluation of pemetrexed (LY231514, IND #40061) in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: A study of the gynecologic oncology group
- (2017) D. S. Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II trial of sorafenib in persistent or recurrent epithelial ovarian cancer (EOC) or primary peritoneal cancer (PPC): A Gynecologic Oncology Group (GOG) study
- (2017) D. Matei et al. JOURNAL OF CLINICAL ONCOLOGY
- AZD2281 (KU-0059436), a PARP (poly ADP-ribose polymerase) inhibitor with single agent anticancer activity in patients with BRCA deficient ovarian cancer: Results from a phase I study
- (2017) P. C. Fong et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Intraperitoneal Carboplatin With Intravenous Paclitaxel in Patients With Suboptimal Residual Epithelial Ovarian or Primary Peritoneal Cancer
- (2010) Keiichi Fujiwara et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009
- (2009) Amy D. Tiersten et al. GYNECOLOGIC ONCOLOGY
- Intraperitoneal chemotherapy for ovarian cancer: 2009 goals
- (2009) Joan L. Walker GYNECOLOGIC ONCOLOGY
- Impact on survival of 12 versus 3 monthly cycles of paclitaxel (175 mg/m2) administered to patients with advanced ovarian cancer who attained a complete response to primary platinum-paclitaxel: Follow-up of a Southwest Oncology Group and Gynecologic Oncology Group phase 3 trial
- (2009) Maurie Markman et al. GYNECOLOGIC ONCOLOGY
- Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer
- (2009) Ursula A. Matulonis et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
- (2009) Michael A. Bookman et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Observation Versus Six Courses of Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer in Complete Response After Six Courses of Paclitaxel/Platinum-Based Chemotherapy: Final Results of the After-6 Protocol 1
- (2009) Sergio Pecorelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- CA125 decline in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy
- (2008) Debra L. Richardson et al. GYNECOLOGIC ONCOLOGY
- Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer
- (2008) Debra L. Richardson et al. GYNECOLOGIC ONCOLOGY
- Phase II Study of Carboplatin and Pemetrexed for the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer
- (2008) Ursula A. Matulonis et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia
- (2007) Agustin A. Garcia et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More